Earnings History Data for Eyenovia, Inc. (EYEN) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Eyenovia, Inc.
Eyenovia, Inc. is a clinical stage biopharmaceutical company which engages in developing therapeutics for the treatment of prominent eye diseases primarily in the United States. Its product portfolio includes MicroProst, MicroStat, MicroTears and MicroPine which are in clinical stage. Eyenovia, Inc. is based in New York.
Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12-11-2024 | AH | EYEN | Eyenovia, Inc. | 37.62 | -0.11 | -0.13 | -0.18 | Eyenovia GAAP EPS of -$0.11 in-line, revenue of $1.62M beats by $1.51M [11/12/2024 4:46 PM] |
0.41 | -0.10 (-18.86%) |
0.49 | -0.02 (-3.23%) |
0.37 - 2.57 | 3,675,031 | 710,000 | 58,692 | ||
12-08-2024 | AH | EYEN | Eyenovia, Inc. | 47.51 | -0.18 | -0.17 | -0.16 | Eyenovia GAAP EPS of -$0.21 misses by $0.06, revenue of $22.63M [8/12/2024 4:08 PM] |
0.7751 | -0.10 (-11.72%) |
0.84 | -0.04 (-4.33%) |
0.50 - 2.57 | 1,108,456 | 1,190,000 | 12,769 | ||
15-05-2024 | AH | EYEN | Eyenovia, Inc. | 38.65 | -0.18 | -0.25 | -0.15 | Eyenovia GAAP EPS of -$0.23 [5/15/2024 5:36 PM] |
0.8209 | -0.24 (-22.56%) |
0.88 | -0.18 (-16.98%) |
0.50 - 3.64 | 1,466,670 | 1,260,000 | 140,019 | ||
18-03-2024 | AH | EYEN | Eyenovia, Inc. | 71.04 | -0.18 | -0.17 | -0.17 | Eyenovia GAAP EPS of -$0.18 misses by $0.01, revenue of $2.58M beats by $2.46M [3/18/2024 4:13 PM] |
1.19 | -0.34 (-21.96%) |
1.40 | -0.13 (-8.50%) |
1.05 - 5.85 | 3,115,825 | 1,230,000 | 49,806 | ||
13-11-2023 | AH | EYEN | Eyenovia, Inc. | 46.43 | -0.18 | -0.19 | -0.21 | Eyenovia GAAP EPS of -$0.18 in-line, revenue of $1.19M beats by $1.03M [11/13/2023 4:21 PM] |
1.28 | 0.09 (7.56%) |
1.27 | 0.08 (6.72%) |
1.05 - 5.85 | 468,374 | 370,000 | 7,338 | ||
10-08-2023 | AH | EYEN | Eyenovia, Inc. | 78.29 | -0.16 | -0.20 | -0.22 | Eyenovia GAAP EPS of -$0.16 beats by $0.01 [8/10/2023 5:49 PM] |
2.08 | 0.05 (2.46%) |
2.13 | 0.10 (4.93%) |
1.50 - 5.85 | 158,678 | 170,000 | 4,284 | ||
11-05-2023 | AH | 4:05 PM ET (May 11) |
EYEN | Eyenovia, Inc. | 161.46 | -0.15 | -0.19 | -0.24 | Eyenovia GAAP EPS of -$0.15 beats by $0.04 [5/11/2023 4:18 PM] |
3.47 | -0.61 (-14.95%) |
3.69 | -0.39 (-9.56%) |
1.50 - 5.85 | 1,765,606 | 1,010,000 | 43,070 | |
30-03-2023 | AH | 4:05 PM ET (Mar 30) |
EYEN | Eyenovia, Inc. | 115.23 | -0.17 | -0.21 | 0.10 | Eyenovia GAAP EPS of -$0.17 beats by $0.03 [3/30/2023 4:23 PM] |
3.56 | 0.38 (11.95%) |
3.41 | 0.23 (7.23%) |
1.50 - 3.68 | 638,830 | 130,000 | 3,758 | |
10-11-2022 | AH | 4:05 PM ET (Nov 10) |
EYEN | Eyenovia, Inc. | 66.03 | -0.21 | -0.20 | -0.23 | Eyenovia GAAP EPS of -$0.21 [11/10/2022 4:37 PM] |
1.85 | 0.07 (4.21%) |
2.00 | 0.22 (12.36%) |
1.52 - 4.21 | 322,271 | 180,000 | 822 | |
10-08-2022 | AH | 4:05 PM ET (Aug 10) |
EYEN | Eyenovia, Inc. | 60.42 | -0.22 | -0.18 | -0.19 | 3.76 | -0.21 (-5.29%) |
1.77 | 0.02 (1.14%) |
3.68 - 12.42 | 14,481 | 20,000 | 2,271 | ||
12-05-2022 | AH | 4:05 PM ET (May 12) |
EYEN | Eyenovia, Inc. | 65.93 | -0.24 | 0.00 | -0.21 | Eyenovia GAAP EPS of -$0.24 misses by $0.01 [5/12/2022 4:12 PM] |
2.16 | 0.24 (12.50%) |
0.0 | 0.0 (0.00%) |
1.83 - 6.63 | 108,003 | 170,000 | 0 | |
28-03-2022 | AH | 4:05 PM ET (Mar 28) |
EYEN | Eyenovia, Inc. | 96.34 | 0.10 | 0.00 | -0.17 | Eyenovia GAAP EPS of $0.10 beats by $0.32, revenue of $10M [3/28/2022 4:13 PM] |
3.19 | 0.19 (6.33%) |
3.29 | 0.29 (9.67%) |
2.62 - 6.63 | 199,841 | 70,000 | 1,059 | |
11-08-2021 | AH | 4:05 PM ET (Aug 11) |
EYEN | Eyenovia, Inc. | 111.18 | -0.19 | -0.24 | -0.25 | Eyenovia EPS beats by $0.04 [8/11/2021 4:14 PM] |
4.23 | -0.14 (-3.20%) |
4.37 | 0.0 (0.00%) |
2.90 - 7.72 | 63,102 | 90,000 | 110 | |
12-05-2021 | AH | 4:05 PM ET (May 12) |
EYEN | Eyenovia, Inc. | 119.41 | -0.21 | -0.22 | -0.31 | Eyenovia EPS beats by $0.01 [5/12/2021 4:16 PM] |
4.37 | -0.27 (-5.82%) |
0.0 | 0.0 (0.00%) |
2.55 - 7.72 | 117,257 | 50,000 | 0 | |
25-03-2021 | AH | 4:05 PM ET (Mar 25) |
EYEN | Eyenovia, Inc. | 145.32 | -0.17 | -0.21 | -0.31 | Eyenovia reports Q4 results [3/25/2021 4:16 PM] |
5.70 | 0.30 (5.56%) |
5.51 | 0.11 (2.04%) |
2.18 - 7.72 | 86,857 | 90,000 | 100 | |
10-11-2020 | AH | 4:05 PM ET (Nov 10) |
EYEN | Eyenovia, Inc. | 82.94 | -0.23 | -0.14 | -0.29 | Eyenovia EPS misses by $0.05 [11/10/2020 4:34 PM] |
3.42 | -0.01 (-0.29%) |
3.40 | -0.03 (-0.87%) |
1.11 - 6.92 | 148,706 | 141,635 | 9,913 | |
|
||||||||||||||||||
12-08-2020 | AH | 4:05 PM ET (Aug 12) |
EYEN | Eyenovia, Inc. | 71.98 | -0.25 | -0.21 | -0.44 | Eyenovia EPS misses by $0.01 [8/12/2020 4:18 PM] |
4.61 | -0.49 (-9.62%) |
4.65 | -0.45 (-8.82%) |
1.11 - 6.92 | 532,156 | 6,309,527 | 24,089 | |
|
||||||||||||||||||
13-05-2020 | AH | 4:05 PM ET (May 13) |
EYEN | Eyenovia, Inc. | 73.17 | -0.31 | -0.31 | -0.50 | Eyenovia EPS misses by $0.01 [5/13/2020 4:09 PM] |
3.20 | -0.40 (-11.11%) |
3.49 | -0.11 (-3.06%) |
1.11 - 5.90 | 74,288 | 24,387 | 150 | |
|